Precision Medicine
Understanding The Science
Medication non-adherence affects nearly 50% of patients with chronic conditions, often leading to complications, suboptimal treatment outcomes, and increased healthcare costs. This challenge arises due to factors such as treatment side effects, socioeconomic barriers, and behavioral influences. Notably, 95% of individuals carry genetic variations that influence how they respond to medications. Changes in enzymes (e.g., the CYP450 family), transporters, and receptors can significantly impact drug metabolism and effectiveness, potentially causing harmful side effects.
At maMEDS, we offer holistic, hybrid (physical) solutions to address these challenges. Our comprehensive digital platform creates secure, personalised treatment plans tailored to poly-pharmacy therapies for patients who understand their genetic profile and receive clinical recommendations.
By leveraging pharmacogenetic data, our platform develops precise therapeutic approaches aligned with each patient’s unique genetic makeup, optimising drug efficacy and reducing adverse effects.
We are committed to enhancing medication adherence through innovative, personalised healthcare solutions. By integrating advanced technology with deep pharmacogenetic insights, we aim to revolutionise patient care, improve treatment outcomes, and promote health literacy in the fight against medication non-adherence.
